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Background: After the 2009 influenza A(H1N1)pdm09 pandemic, China established its first severe acute respiratory
infections (SARI) sentinel surveillance system.
Methods: We analyzed data from SARI cases in 10 hospitals in 10 provinces in China from February 2011 to
October 2013.
Results: Among 5,644 SARI cases, 330 (6%) were influenza-positive. Among these, 62% were influenza A and 38%
were influenza B. Compared with influenza-negative cases, influenza-positive SARI cases had a higher median age
(20.0 years vs.11.0, p = 0.003) and were more likely to have at least one underlying chronic medical condition (age
adjusted percent: 28% vs. 25%, p < 0.001). The types/subtypes of dominant strains identified by SARI surveillance was
almost always among dominant strains identified by the influenza like illness (ILI) surveillance system and influenza
activity in both systems peaked at the same time.
Conclusions: Data from China’s first SARI sentinel surveillance system suggest that types/subtypes of circulating
influenza strains and epidemic trends among SARI cases were similar to those among ILI cases.
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In 2005, China established a national influenza-like ill-
ness (ILI) surveillance system to monitor influenza activ-
ity and to describe the epidemiology of influenza among
outpatients and the virologic characteristics of circulat-
ing virus [1]. The A(H1N1)pdm09 influenza pandemic
of 2009 underscored the importance of establishing sys-
tems to monitor severe disease. When the World Health
Organization reissued its recommendation for Member* Correspondence: yuhj@chinacdc.cn
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unless otherwise stated.States to develop surveillance systems for severe acute
respiratory infection (SARI) among inpatients [2,3], China
selected 10 sentinel hospitals in 10 provinces and their
corresponding influenza laboratories from the national
ILI surveillance network to initiate SARI surveillance
among hospitalized patients [Figure 1]. These hospitals
were selected based on regional representativeness and
demonstrated capacity to conduct ILI surveillance. In
February 2011, the Ministry of Health released a revised
protocol to enhance surveillance of severe respiratory
infections and more specifically, severe infections with
laboratory-confirmed influenza [4].
We analyzed data from China’s first SARI surveillance
system during its initial 33 months, from February 2011
to October 2013, to characterize the epidemiology andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Location of 10 sentinel sites for severe acute respiratory infection (SARI) surveillance in China. The Qinling Mountain – Huaihe
River serves as the dividing line between north and south China. This border is located at 32- 34°northern latitude. North China has a monsoon
climate of medium latitudes, while south China has a subtropical monsoon climate.
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Sentinel surveillance was conducted at ten general hospi-
tals located in the largest cities of ten provinces in China.
In each hospital, surveillance was conducted within the
pediatrics ward, the respiratory medicine ward and the
intensive care unit. The number of beds in these wards
combined was greater than 80 in each of the ten hospitals.
Patient enrollment
All patients admitted to surveillance wards at the 10
hospitals were screened by nurses and physicians for
SARI. A patient >5 years old was defined as having SARI
if, upon or during admission, they presented with an
acute onset of elevated temperature (axillary temperature
≥38°C) and cough or sore throat, AND tachypnea (re-
spiratory rate ≥ 25/min) or dyspnea (difficulty breathing).
A patient ≤5 years old was defined as having SARI if,upon or during admission, they presented with acute on-
set of cough or dyspnea, AND at least one of the follow-
ing six signs or symptoms: a) tachypnea (respiratory rate
>60/min for ages <2 months, respiratory rate >50/min
for ages 2 to <12 months, and respiratory rate >40/min
for ages 1 to ≤5 years); b) inability to drink or breastfeed;
c) vomiting; d) convulsions; e) lethargy or unconscious-
ness; f ) chest in-drawing OR stridor in a calm child [5].
Per China’s Ministry of Health national influenza surveil-
lance guidelines implemented in October 2009, collection
and analysis of data for this project were considered offi-
cial public health surveillance activities and institutional
review board approval was not required [6].
Patient data collection
Upon enrollment, physicians registered the SARI case-
patient’s name, gender, and date of illness onset. During
the hospital admission, physicians completed a standard-
ized case report form (CRF) that recorded demographic
information, chronic medical conditions, signs and symp-
toms of current illness, and laboratory and radiographic
data. At hospital discharge, physicians updated the form
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including treatment received, complications and outcomes.
Specimen collection and testing
Nurses collected nasopharyngeal (NP) swabs from SARI
case-patients within 24 hours of enrollment following
standardized procedures. Swabs were immediately placed
in viral transport medium (VTM) and stored at 4°C at the
local hospital. These specimens were transferred to the
closest influenza network laboratory (provincial or prefec-
ture Center for Disease Control and Prevention (CDC)
laboratories) within 48 hours of collection. The local in-
fluenza network laboratories stored the specimens in
VTM at −70°C until they conducted testing by real-time
reverse transcription PCR (rRT-PCR) following the stand-
ard protocol [7,8].
Data analysis
Based on influenza activity, climate and geography, we
divided China into two distinct regions, north and south,
for the analysis and interpretation of influenza surveil-
lance data. The Qinling Mountain – Huaihe River serves
as the dividing line between north and south China
[9-12]. In our sentinel surveillance system, 4 hospitals
are located in north China, while 6 are located in south
China [Figure 1].
Hospital infection control and local CDC staff entered
epidemiologic, clinical, and laboratory data into an elec-
tronic database that was transmitted weekly to the na-
tional China CDC. We defined a patient with laboratory-
confirmed influenza as any SARI case-patient with an NP
swab that tested positive for influenza virus by rRT-PCR.
We analyzed data that were collected from February 1,
2011- October 27, 2013 with SPSS (v13.0, SPSS, Chicago,
IL, USA). Descriptive statistics included frequency ana-
lysis for categorical variables such as gender, age group,
underlying chronic medical conditions, clinical character-
istics and outcomes. We calculated medians and inter-
quartile ranges for continuous variables such as age and
length of clinical course. Differences in demographic and
clinical characteristics and outcomes were assessed
among SARI patients with and without laboratory-
confirmed influenza using the chi-squared test or the
Fisher’s exact test for nominal variables. We calculated
age-adjusted mortality rates using standard techniques
[13], with the 2010 China population census serving as
the reference population [14]. We used the Wilcoxon
rank sum test for ordinal variables. Differences were con-
sidered statistically significant at P < 0.05.
ILI surveillance in China
Ten hospitals included in the sentinel SARI surveillance
system were also ILI sentinel hospitals within the national
influenza surveillance system. We compared influenzaactivity among SARI and ILI patients using surveillance
data from the outpatient departments of the ten hospitals
in the SARI surveillance system from February 2011 –
October 2013.
The Chinese national influenza-like illness (ILI) surveil-
lance system currently includes 409 network laboratories
and 554 sentinel hospitals. Surveillance is conducted in
sentinel hospital emergency rooms and internal medicine
and pediatric outpatient departments. Each surveillance
department registers the number of ILI patients seen each
day to calculate the proportion of all medical visits that
are due to ILI [8]. NP swabs are collected from a sample
of ILI patients, and are sent to the nearest network
laboratory for influenza testing with rRT-PCR and add-
itional virologic analyses.
Results
From February 1, 2011 – October 27, 2013, 155,639
patients were hospitalized in the surveillance wards of
the ten sentinel hospitals. Among these, 5,644 (4%) met
the case definition for SARI and NP swab specimens
were collected for all 5,644. CRFs were completed for
5,268 (93%). Among all SARI cases, 330 (6%) tested
positive for influenza by rRT-PCR, and among these,
CRFs were completed for 299 (91%).
Characteristics of SARI patients
Of the 5,268 SARI patients with completed CRFs, 794
(14.2%) were children <1 year old, 1386 (26.3%) were
children 1 to <5 years old, and 1050 (19.9%) were adults
≥65 years old [Table 1]. SARI patients had a median age
of 12.0 years (interquartile range [IQR], 2.0 - 58.0 years),
and 3091 (59%) were male.
Just under 85% of SARI case-patients reported a
temperature of ≥38°C after illness onset, with a median
peak temperature of 39.0°C (IQR, 38.5 - 39.5°C). After
fever, the most common clinical symptom or sign was
cough (80%). Among SARI patients, 1,189 (23%) were
clinically diagnosed with pneumonia during their hos-
pital admission, and 2,868 (54%) had at least one abnor-
mal finding on chest X-ray. The median duration of
hospitalization was 8 days (IQR, 6–12.5), and 61 (1.2%)
patients were admitted to an intensive care unit. Ninety-
eight (1.9%) patients died during their hospitalization.
Among SARI case-patients, 1,407 (27%) had at least one
chronic medical condition, such as cardiovascular dis-
ease, chronic obstructive pulmonary disease, diabetes
mellitus, chronic bronchitis, cancer/tumor, and asthma.Characteristics of patients with laboratory-confirmed
influenza
Of 299 SARI patients with laboratory-confirmed influ-
enza, 101 (34%) were <5 years old, 145 (48%) were
Table 1 Characteristics of hospitalized severe acute respiratory infection (SARI) patients and laboratory-confirmed
influenza patients in 10 sentinel surveillance hospitals in 10 provinces, China, February 1, 2011 to October 27, 2013
Characteristics All SARI patients
(%) [n = 5,268]a
SARI patients with
confirmed influenza
(%) [n = 299]a
SARI patients without
confirmed influenza
(%) [n = 4,678]a
p value
Male sex 3,091 (58.7) 193 (64.5) 2,725 (58.3) 0.202
Age, median (interquartile range [IQR], years) 12.0 (2.0-58.0) 20.0 (3.0-67.0) 11.0 (2.0-56.0) 0.003*
Age group
<6 months 357(6.8) 11 (3.7) 335 (7.2) <0.001*
6 - 11 months 392 (7.4) 15 (5.0) 362 (7.7)
12 - 23 months 458 (8.7) 24 (8.0) 411 (8.8)
2 - 4 years 928 (17.6) 51 (17.1) 836 (17.9)
5 - 9 years 412 (7.8) 37 (12.4) 351 (7.5)
10 - 14 years 137 (2.6) 7 (2.3) 125 (2.7)
15 - 49 years 976 (18.5) 38 (12.7) 886 (18.9)
50 - 64 years 554 (10.5) 35 (11.7) 476 (10.2)
≥65 years 1050 (19.9) 81 (27.1) 896 (19.2)
Underlying chronic medical conditions
At least oneb 1407 (26.7) 111 (37.1) 1296 (27.7) <0.001*
Cardiovascular disease 792 (15.0) 64 (21.5) 728 (15.6) <0.001*
Chronic obstructive pulmonary diseasec 198 (3.8) 23 (7.7) 175 (3.7) 0.064
Diabetes mellitus 244 (4.6) 22 (7.4) 222 (4.7) 0.215
Chronic bronchitis 205 (3.9) 22 (7.4) 183 (3.9) 0.049*
Cancer/Tumor 138 (2.6) 13 (4.3) 125 (2.7) 0.043*
Asthma 85 (1.6) 2 (0.7) 83 (1.8) 0.040*
Vaccinated with seasonal influenza vaccine during past year 47 (1.1) 6 (2.7) 41 (1.1) 0.041*
Clinical history and physical examination
Fever 4440 (84.3) 284 (95.0) 4156 (88.8) <0.001*
Highest temperature after onset, median (interquartile range [IQR], °C) 39.0 (38.5-39.5) 39.0 (38.6-39.6) 39.0 (38.5-39.5) 0.072
Abnormal breath sounds on auscultation 2950 (60.0) 196 (65.6) 2754 (58.9) 0.071
Cough 4235 (80.4) 256 (85.6) 3979 (85.1) 0.592
Sore throat 1661 (31.5) 103 (34.4) 1558 (33.3) 0.028*
Difficulty breathing 1449 (27.5) 112 (37.5) 1387 (29.6) 0.012*
Clinical pneumonia
Abnormal chest X-ray performance 2868 (54.4) 176 (58.9) 2692 (57.5) 0.992
Diagnosis of clinical pneumonia 1189 (22.6) 66 (22.1) 1123 (24.0) 0.925
Clinical course, median (IQR), days
From illness onset to hospital admission 3 (1–6) 2.5 (1–5) 3 (1–6) 0.802
Length of stay in hospital 8 (6–12.5) 9 (6.75-14) 8 (5–12) 0.593
Admission to ICUd 61 (1.2) 5 (1.7) 56 (1.2) 0.840
Deathe 98 (1.9) 12 (4.0) 86 (1.8) 0.013*
aData are presented as no. (%) of patients unless otherwise indicated. Denominators for testing are indicated. Percentages may not total 100 because of rounding.
As a proportion of SARI case patients did not have influenza testing results, the sum of all patients with and without confirmed influenza is not equal to the total
number of SARI patients.
bAt least one underlying medical condition defined as: admission diagnosis of any of the following: chronic obstructive pulmonary disease, asthma, cardiovascular
disease, diabetes mellitus, chronic bronchitis, or cancer/tumor.
cChronic obstructive pulmonary disease defined as a lung disease characterized by chronic obstruction of lung airflow that interferes with normal breathing and is
not fully reversible.
dICU denotes intensive care unit.
eDuring hospitalization.
*The symbol bold data means p<0.05.
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The distribution of cases by age category was different
among SARI cases with and without confirmed influenza
[Figure 2]. The proportion of SARI cases with confirmed
influenza was higher among those aged > = 65 years (27%
vs. 19%, p = 0.001) and those 5–9 years old (12.4% vs
7.5%, p = 0.002) and lower among those <1 year old (8.7%
vs. 14.9, p = 0.003) and those aged 15–49 years (12.7% vs.
18.9%, p = 0.007). Influenza types/subtypes detected in-
cluded A(H1N1)pdm09 influenza (pH1N1) (100, 33%), A
(H3N2) (80, 27%), A (subtype not identified) (4, 1%), and
influenza B (115, 38%). The SARI patients with con-
firmed influenza had a significantly higher median age
than those without confirmed influenza (20.0 years vs.
11.0, p = 0.003), and more often had at least one chronic
medical condition (37% vs. 28%, p < 0.001; age adjusted
percentage 28% vs. 25%, p < 0.001) including cardiovascu-
lar disease (22% vs. 16%, p < 0.001), chronic bronchitis (7%
vs. 4%, p < 0.05), and cancer/tumor (4% vs. 3%, p < 0.05)
[Table 1]. Although asthma was uncommon in both
groups, it was less common among SARI patients with
confirmed influenza (1% vs. 2%, p < 0.05). Compared with
SARI patients without confirmed influenza, those with
confirmed influenza more frequently had fever (95% vs.
89%, p < 0.001), sore throat (34% vs. 33%, p < 0.05) and dif-
ficulty breathing (38% vs. 30%, p < 0.05). SARI patients
with confirmed influenza were no more likely to have clin-
ical pneumonia than SARI patients without confirmed in-
fluenza (22.1% vs. 24.0%, p = 0.925). Mortality was higher
among influenza positive SARI patients than influenza
negative patients (4.0% vs. 1.8%, p = 0.013), but there was
no significant difference after age adjustment (2.7% vs.
1.5%, p = 0.137). Receipt of seasonal influenza vaccination
in the prior year was low among both SARI patients with
and without confirmed influenza (2.7% vs. 1.1%, p = 0.041).
Of 1,260 SARI patients with clinical pneumonia, 1,189
(94%) had an NP swab specimen tested, and 66 (6%)Figure 2 Proportion of severe acute respiratory infection (SARI) patie
Febuary 1, 2011 to October 27, 2013.tested positive for influenza virus including pH1N1 (21,
32%), A(H3N2) (11, 17%), and influenza B (28, 42%).Temporal trends
North 4 sentinel hospitals
In the 4 sentinel hospitals in the north, there was a
winter-spring seasonal peak (December to May each year)
in SARI patients during the 33 month surveillance period
[Figure 3, Panel A]. Similarly, there was an increase in
influenza activity during the winter (December to
February) and spring months (March to May) [Figure 3,
Panel A]. During the study period, the predominant types/
subtypes of influenza virus in the north based on isolates
from SARI patients were different for each seasonal peak
of influenza activity; pH1N1 predominated during the
2011 spring peak (accounting for 33% of isolates collected
March-May), B during the 2011–2012 winter peak
(accounting for 87% of isolates collected December-
February), A(H3N2) during the 2012 spring months
(accounting for 50% of isolates collected March-May), and
pH1N1 during the 2012–2013 winter months and 2013
spring months (accounting for 57% of isolates collected
December-February and 100% of isolates collected
March-May 2013) [Figure 4, Panel A].South 6 sentinel hospitals
In the south, data from the 33 month surveillance period
revealed a winter-seasonal peak in SARI patients [Figure 3,
Panel B]. There was also an increase in influenza activity
during the winter (December to March) and spring
months (March to May). In addition, there was an in-
crease in influenza activity during the summer months
(July to August) [Figure 3, Panel B]. In contrast to the
north, in the 2011–2012 and 2012–2013 influenza seasons
in the south, influenza activity peaked during months
when the numbers of hospitalized SARI cases were not atnts with and without confirmed influenza by age group, China,
AB
Figure 3 Hospitalized severe acute respiratory infection (SARI) patients and patients with confirmed influenza virus infection by month
of illness onset, China, Febuary 1, 2011 to October 27, 2013. Panel A. Four Northern Hospitals: SARI patients (N=2,780) and patients with
confirmed influenza virus infection (n=187). Panel B. Six Southern Hospitals: SARI patients (N=2,858) and patients with confirmed influenza virus
infection (n=143). *SARI% = proportion of severe acute respiratory infection (SARI) patients among all hospitalized patients in the surveillance
wards.
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enza activity and SARI cases peaked at the same time.
The predominant types/subtypes of influenza virus in
the south based on isolates from SARI patients were
pH1N1 during 2011 spring months (accounting for
35% of isolates collected March-May), B during 2011–
2012 winter months (accounting for 71% of isolates
collected December-February), A(H3N2) during 2012
spring months (accounting for 64% of isolates col-
lected March-May), A(H3N2) and B during 2012 sum-
mer months (accounting for 63% and 37% of isolates
collected July-August), and pH1N1 during the 2012–
2013 winter months, 2013 spring months and 2013
summer months (accounting for 53% of isolates col-
lected December-February; 83% of isolates collected
March-May and 63% of isolates collected July-August)
[Figure 4, Panel B]. Similar to the north, the predom-
inant types/subtypes of circulating influenza virus in
the south for both the winter and spring months of
every influenza season were the same.
Comparison with influenza like illness (ILI) surveillance
In the 4 hospitals in the north, the influenza activity
among ILI patients peaked in the winter-spring eachyear, similar to influenza activity among SARI patients
[Figure 5]. Also, as seen with SARI patients, the predom-
inant types/subtypes of virus among ILI patients varied
from season to season [Figure 4]. During the study
period, the types/subtypes of influenza virus among ILI
patients in the north were predominantly pH1N1 and B
during 2011 spring months (accounting for 14% and
78% of isolates collected March-May), B during 2011–
2012 winter months (accounting for 93% of isolates col-
lected December-February), B and A(H3N2) during 2012
spring months (accounting for 73% and 31% of isolates
collected March-May), A(H3N2) and pH1N1 during
2012–2013 winter months (accounting for 54% and 45%
of isolates collected December-February), and pH1N1
during 2013 spring months (accounting for 64% of iso-
lates collected March-May).
In the 6 hospitals in the south, the influenza activity
among ILI patients peaked in both the winter-spring
months and summer months each year [Figure 5]. In the
south, the predominant types/subtypes of virus among ILI
patients also differed from season to season [Figure 4].
During the study period, the types/subtypes of influenza
viruses among ILI patients were predominantly pH1N1
and B during 2011 spring months (accounting for 33%
AB
Figure 4 Number of influenza positive by type/subtype and by month of illness onset among hospitalized severe acute respiratory
infection (SARI) patients and influenza like illness (ILI) outpatients in ten sentinel hospitals, China, Febuary 1, 2011 to October 27,
2013*. Panel A. Four Northern Hospitals. Panel B. Six Southern Hospitals. *The bars with diagonal slashes indicate isolates from ILI patients, while
the solid bars indicate isolates from SARI patients.
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2011–2012 winter months (accounting for 81% of iso-
lates collected December-February), B and A(H3N2)
during 2012 spring months (accounting for 36% and
62% of isolates collected March-May), A(H3N2) during
2012 summer months (accounting for 97% of isolates
collected July-August), pH1N1 during 2012–2013 win-
ter months and 2013 spring months (accounting for
81% of isolates collected December-February and 86%
of isolates collected March-May), and A(H3N2) during
2013 summer months (accounting for 77% of isolates
collected July-August).
In both the north and the south, the predominant
types/subtypes of influenza strains among SARI patients
in each season were among the predominant types/sub-
types of influenza strains circulating among ILI patients
for that season [Figures 4 and 5].
Discussion and conclusions
This paper describes data from the first SARI sentinel
surveillance system among hospitalized patients in China,
focusing on those with laboratory-confirmed influenza
from February 2011 to October 2013. More than 60% ofSARI patients with confirmed influenza were children
< 5 years of age and adults 65 years of age and older.
This is consistent with findings from other studies that
demonstrate the heaviest burden of severe influenza
disease within these two age groups [15,16].
Many studies have reported that seasonal influenza
causes more severe disease and more often leads to
hospitalization in certain populations, including children
aged < 5 years, adults aged ≥65 years, pregnant women,
and persons with chronic medical conditions [15,16]. In
our study, a greater proportion of SARI patients with
confirmed influenza had at least one underlying chronic
medical condition, compared with SARI patients without
influenza. Although our study did not measure risk for
severe disease among all patients with influenza, the
high burden of chronic disease among hospitalized SARI
patients with influenza in our surveillance system is con-
sistent with other studies. One study in the US reported
49% of children hospitalized with community-acquired
laboratory-confirmed influenza had at least one chronic
medical condition [17]. Another study in China reported
that the prevalence of chronic medical conditions among
patients with severe illness due to the 2009 pandemic
AB
Figure 5 Percent of influenza positive by month of illness onset among hospitalized severe acute respiratory infection (SARI) patients
and influenza like illness (ILI) outpatients, China, Febuary 1, 2011 to October 27, 2013. Panel A. Four Northern Hospitals. Panel B. Six
Southern Hospitals. *positive rate (%): (1) ILI flu positive rate = percent of influenza positive specimens among all tested specimens for influenza
like illness patients. (2) SARI flu positive rate=percent of influenza positive specimens among all tested specimens for severe acute respiratory
infection patients.
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14% for those with mild illness [18]. Having an under-
lying chronic medical condition also increased the risk
of influenza-related death [15,16].
Our study, similar to prior studies, found that respira-
tory disease and cardiovascular disease were two of the
most common chronic medical conditions among SARI
patients with influenza [15,16,18,19]. The most common
respiratory conditions in our study included chronic
obstructive pulmonary disease (COPD) and chronic
bronchitis. In contrast to a prior study of SARI patients
in central China [20], SARI patients with confirmed
influenza in our study were less likely to have asthma
than patients without influenza. This finding warrants
further investigation within a larger study population,
however, as the number with diagnosed asthma in both
SARI patients with and without influenza was low.
In our study, vaccination with seasonal influenza vac-
cine in the prior year was low (<3%) in both SARI
patients with and without confirmed influenza. Cur-
rently, although Chinese Center for Disease Control and
Prevention recommends seasonal influenza vaccination
for those at high risk for severe illness from influenza,including pregnant women, young children, the elderly
and persons with chronic illness [21], seasonal influenza
vaccination is not included in the national immunization
program. As China expands seasonal influenza vaccin-
ation in the future, data from the SARI surveillance sys-
tem can inform seasonal vaccination timing decisions.
In this study, influenza activity among SARI cases in
northern China increased in the colder winter months
(December-March), and spring months (March-May),
consistent with the distinct winter-spring peak in the
north seen in other studies [4,5,19]. These data suggest
that the optimal time to launch annual influenza vaccin-
ation campaigns in northern China is the fall, prior to
increased influenza activity. This is consistent with the
current practice in China, where influenza vaccination
promotion begins in October [21]. In southern China,
influenza circulated year-round, suggesting that add-
itional studies are needed to inform optimal timing of
vaccination campaigns in the south. China’s complex cli-
mate and geography and diverse socio-economic and
demographic characteristics lead to varied seasonal influ-
enza patterns, especially in southern China [6]. Continu-
ing, improving and expanding surveillance over several
Peng et al. BMC Infectious Diseases  (2015) 15:143 Page 9 of 10years will increase understanding of influenza seasonality
by region.
Data from China’s SARI surveillance system provide
important evidence on types/subtypes of virus causing
severe influenza illness. Though the timing of northern
China’s peak influenza activity is similar to that seen in
North America and Europe, the types/subtypes of pre-
dominant strains based on isolates from SARI patients
in our study were not always consistent with the pre-
dominant types/subtypes identified in these other re-
gions during the same winter influenza peaks [22-24].
Within China, however, the predominant types/subtypes
of virus from SARI patients in each winter-spring influ-
enza season were the same in the north and the south.
The predominant types/subtypes of virus causing se-
vere influenza disease varied by year for each of the
three winter peaks of this study. In the spring months,
the predominant types/subtypes were the same in 2011
and 2013, but different in 2012. This temporal variation
of predominant type/subtype was also seen within the
ILI surveillance system [25]. Of note, the ILI surveillance
system detected more than one predominant type/sub-
type in certain influenza seasons. The predominant type/
subtype identified by the SARI surveillance system, how-
ever, was almost always among the predominant type/
subtype identified by the ILI system. This finding has
reassuring implications for vaccine candidate strain se-
lection, as recommendations for strain inclusion within
the vaccine are based on the ILI surveillance system.
Our study is prone to a number of limitations. First,
we analyzed data from 33-months, a period not enough
to predict the seasonal trends of influenza activity and to
assess influenza disease burden. Second, given China’s
geographic and economic diversity, data from ten senti-
nel hospitals are not representative of the entire country.
Representativeness will improve as sentinel sites are
added to this new surveillance system [26]. Third, this
paper describes findings from the initial months of the
SARI surveillance system in China, when data quality
was inconsistent. It is likely that some cases were not
captured by the system, and 7% of the CRFs were missing.
Further, only 29% of SARI cases were swabbed within
24 hours of hospital admission (31% among influenza-
positive SARI patients and 29% among influenza-negative
SARI patients, p = 0.509) which may have increased the
false negative rate for influenza. Finally, because we
were not able to define the catchment populations for
the ten sentinel hospitals, we were unable to calculate
hospitalization rates for influenza infection. Additional
health utilization surveys are necessary to assess dis-
ease burden in the future [27].
This is the first study to describe laboratory-confirmed
influenza activity among SARI patients hospitalized in ten
sentinel sites of China. These surveillance data informinfluenza prevention and control strategies. Vaccine strain
selection is based upon ILI surveillance. Reassuringly, the
types/subtypes of circulating influenza strains and epi-
demic trends among SARI influenza inpatient cases were
similar to those among milder ILI outpatient cases. Con-
tinued and expanded SARI surveillance is necessary to
fully assess the disease burden of influenza, and to de-
scribe the seasonality patterns and influenza strains circu-
lating by region.
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